Browse EX-10 agreements

Veru Inc.

Shares of Common Stock

(par value $0.01 per share)

Sales Agreement

July 2, 2026

Oppenheimer & Co. Inc.

85 Broad Street

New York, New York 10004

Canaccord Genuity LLC

Penn 1, One Pennsylvania Plaza,

Suite 2900

New York, New York 10119

Ladies and Gentlemen:

Veru Inc., a Wisconsin corporation (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc. (“Oppenheimer”) and Canaccord Genuity LLC (“Canaccord” and, together with Oppenheimer, the “Agents” and each an “Agent”), as follows:

 

…

75 Rockefeller Plaza New York, NY 10019 +1 212 220-2660

www.basepointcapital.com

 

STRICTLY PRIVATE & CONFIDENTIAL

 

June 16, 2026

 

TMX MP SPE, LLC

2312 E Trinity Mills Rd., Suite 100 Carrollton, TX 75006

Attention: Kyle Hanson

 

Re:         Master Loan and Security Agreement – Renewal

 

Dear Kyle:

 

TMX MP SPE, LLC, a Delaware limited liability company (“Borrower” or “you”), as Borrower under that certain Master Loan and Security Agreement, dated as of February 10, 2023 (as amended, modified or restated from time to time, the “Credit Facility”) has advised BP Commercial Funding Trust II, Series SPL-XVI, a statutory series of BP Commercial Funding Trust II, a Delaware statutory trust, for itself and for no other series of BP Commercial Funding Trust II (“BP Lender” or the “Commitment Parties” or “we” or “us”), that you desire to extend the Draw Period (as defined in the Credit Facility) to December 31, 2027 (the “Extended Term”).

 

This letter is hereinafter referred to as the “Commitment Letter”.

…

Document

Execution Version

FIRST AMENDMENT TO CREDIT AGREEMENT

THIS FIRST AMENDMENT TO CREDIT AGREEMENT dated as of June 29, 2026 (this “Amendment”), is entered into by and among Abacus Global Management, Inc., a Delaware corporation (the “Borrower”), each lender signatory hereto (including, for the avoidance of doubt, each First Amendment Incremental Term Lender (as defined below)) (collectively, the “Lenders” and individually, each a “Lender”), GLAS USA LLC, as Administrative Agent (together with its permitted successors and assigns in such capacity, the “Administrative Agent”) and as Collateral Agent (together with its permitted successors and assigns in such capacity, the “Collateral Agent”):

R E C I T A L S

…

Execution Version

Deal CUSIP: 03265PAV0

Revolver CUSIP: 03265PAW8

 

 

 

CREDIT AGREEMENT

Dated as of July 2, 2026

among

ANALOG DEVICES, INC.,

as the Company and as a Borrower,

CERTAIN SUBSIDIARIES OF THE COMPANY,

as Designated Borrowers,

BANK OF AMERICA, N.A.,

as Administrative Agent,

and

The LENDERS Party Hereto

 

 

CITIBANK, N.A.,

JPMORGAN CHASE BANK, N.A.,

MORGAN STANLEY SENIOR FUNDING, INC.,

BARCLAYS BANK PLC and

BNP PARIBAS SECURITIES CORP.,

as Co-Documentation Agents

BOFA SECURITIES, INC.,

CITIBANK, N.A.,

JPMORGAN CHASE BANK, N.A.,

MORGAN STANLEY SENIOR FUNDING, INC.,

BARCLAYS BANK PLC and

BNP PARIBAS SECURITIES CORP.,

as Joint Lead Arrangers and Joint Bookrunners

---

TABLE OF CONTENTS

 

 

  

 

  

 

  

Page

 

ARTICLE I DEFINITIONS AND ACCOUNTING TERMS

  

 

1

 

  

1.01

  

Defined Terms

  

 

1

 

  

1.02

  

Other Interpretive Provisions

  

 

25

 

  

  

1.03

  

Accounting Terms

  

 

26

 

  

1.04

  

Rounding

  

 

27

 

  

1.05

  

Times of Day

  

 

27

 

  

1.06

…

---

Exhibit 10.1

Execution Version

---

BRIDGE LOAN CREDIT AGREEMENT

among

JEFFERSON 2020 BOND BORROWER LLC,

as the Borrower,

The Several Lenders

from Time to Time Party Hereto

and

JEFFERIES FINANCE LLC,

as Administrative Agent,

Dated as of July 1, 2026

---

Jefferies Finance LLC,

as Sole Lead Arranger, Sole Bookrunner and Sole Syndication Agent

 

---

---

TABLE OF CONTENTS

 

 

Page

 

ARTICLE I

 

 

 

DEFINITIONS

1

Section 1.1

Defined Terms

1

Section 1.2

Other Defined Terms.

23

Section 1.3

Other Definitional Provisions.

25

Section 1.4

Timing of Payment or Performance

26

Section 1.5

Currency Equivalents Generally.

26

Section 1.6

Interest Rates; Benchmark Notification

26

 

 

 

ARTICLE II

 

 

 

LOANS

27

Section 2.1

Loans.

27

Section 2.2

Pro Rata Shares; Availability of Funds.

27

Section 2.3

[Reserved].

28

Section 2.4

Evidence of Debt; Register; Lenders’ Books and Records; Notes.

28

Section 2.5

Interest on Loans.

28

Section 2.6

Conversion/Continuation.

29

Section 2.7

Default Interest

30

Section 2.8

…

XEROX HOLDINGS CORPORATION

2026–2028 TRANSFORMATION RETENTION AWARD PLAN

ARTICLE 1. ESTABLISHMENT AND PURPOSE

Section 1.1 Establishment. Xerox Holdings Corporation (the “Company”) hereby establishes the Xerox Holdings Corporation 2026–2028 Transformation Retention Award Plan (the “Plan”), effective as of July 1, 2026 (the “Effective Date”).

Section 1.2 Purpose. The purpose of the Plan is to promote leadership continuity, operational stability, and the retention of critical talent during the Company’s multi-year transformation, operational restructuring, integration initiatives, and balance sheet strengthening efforts. The Plan is meant to supplement and work in conjunction with — and not to replace — the Company’s other incentive programs, such as its equity plans and severance arrangements, in order to achieve these described purposes. The Plan is intended to be a limited-duration, non-recurring retention program.

ARTICLE 2. DEFINITIONS

Section 2.1 Defined Terms. When used in the Plan, the following terms shall have the meanings set forth below:

…

EXECUTION VERSION

CORPUS CHRISTI LIQUEFIED NATURAL GAS PROJECT

 

 

REVOLVING CREDIT AGREEMENT

 

 

CHENIERE CORPUS CHRISTI HOLDINGS, LLC,

as Borrower,

 

 

CORPUS CHRISTI LIQUEFACTION, LLC,

CHENIERE CORPUS CHRISTI PIPELINE, L.P.,

CORPUS CHRISTI PIPELINE GP, LLC, and

ANY OTHER SUBSIDIARY OF THE BORROWER THAT BECOMES A PARTY HERETO

FROM TIME TO TIME AS A GUARANTOR,

as Guarantors,

 

 

THE LENDERS PARTY HERETO FROM TIME TO TIME,

as Revolving Lenders,

THE ISSUING BANKS PARTY HERETO FROM TIME TO TIME,

as Issuing Banks,

THE SWING LINE LENDERS PARTY HERETO FROM TIME TO TIME,

as Swing Line Lenders,

THE BANK OF NOVA SCOTIA,

as Revolving Facility Agent

and

solely for purposes of Section 3.07,

SOCIÉTÉ GÉNÉRALE,

as Security Trustee

 

 

Dated as of June 26, 2026

 

---

TABLE OF CONTENTS

ARTICLE I

DEFINITIONS AND INTERPRETATION

 

Section 1.01

  

Defined Terms

  

 

2

 

Section 1.02

  

Principles of Interpretation

  

 

2

 

Section 1.03

  

UCC Terms

  

 

2

 

Section 1.04

…

EXECUTION VERSION

SECOND AMENDMENT TO

SECOND A&R TERM LOAN FACILITY AGREEMENT

This Second Amendment, dated as of June 26, 2026 (the “Second Amendment”), amends the Second Amended and Restated Term Loan Facility Agreement, dated as of June 15, 2022 (as amended by the First Amendment, dated as of April 19, 2024, and as further amended, amended and restated, modified or supplemented from time to time, the “Term Loan Facility Agreement”), by and among Cheniere Corpus Christi Holdings, LLC (the “Borrower”), Corpus Christi Liquefaction, LLC, Cheniere Corpus Christi Pipeline, L.P. and Corpus Christi Pipeline GP, LLC (the “Guarantors” and, together with the Borrower, the “Loan Parties”), Société Générale as the Term Loan Facility Agent, and the Term Lenders that are party thereto. All capitalized terms used herein and not otherwise defined shall have the meanings ascribed to such terms in the Term Loan Facility Agreement.

WHEREAS, the Loan Parties wish to enter into this Second Amendment; and

…

SECURITIES PURCHASE AGREEMENT

 

THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is entered into and made effective as of June 29, 2026, by and between TENON MEDICAL, INC., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

 

RECITALS

 

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act (as defined below), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

 

AGREEMENT

 

NOW, THEREFORE, in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

 

ARTICLE I.

DEFINITIONS

…

Document

EXHIBIT 10.1

THIRD AMENDMENT TO CREDIT AGREEMENT

THIS THIRD AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is made as of June 30, 2026, by and among BACKBLAZE, INC., a Delaware corporation (“Borrower”), the other Loan Parties party hereto, and CITIZENS BANK, N.A. (“Lender”).

RECITALS

WHEREAS, Borrower and Lender are parties to that certain Credit Agreement, dated as of June 4, 2025 (as modified, amended and or amended and restated from time to time, the “Credit Agreement”) with respect to certain financial accommodations made available to Borrower by Lender;

WHEREAS, Borrower has requested that Lender amend the Credit Agreement to make certain revisions to the Credit Agreement as more fully set forth herein; and

WHEREAS, Lender has agreed to amend certain provisions of the Credit Agreement in accordance with, and subject to the terms and conditions of, this Amendment.

…

MENTARI THERAPEUTICS, INC.

2025 EQUITY INCENTIVE PLAN

1. Purpose.

The purpose of this 2025 Equity Incentive Plan (the “Plan”) of Mentari Therapeutics, Inc., a Delaware corporation (the “Company”), is to advance the interests of the Company’s stockholders by enhancing the Company’s ability to attract, retain and motivate persons who are expected to make important contributions to the Company and by providing such persons with equity ownership opportunities and performance-based incentives that are intended to better align the interests of such persons with those of the Company’s stockholders. Except where the context otherwise requires, the term “Company” shall include any of the Company’s present or future parent or subsidiary corporations as defined in Sections 424(e) or (f) of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”) and any other business venture (including, without limitation, joint venture or limited liability company) in which the Company has a controlling interest, as determined by the Boa

…

FIRST AMENDMENT TO THE

MENTARI THERAPEUTICS, INC.

2025 EQUITY INCENTIVE PLAN

WHEREAS,Mentari Therapeutics, Inc., a Delaware corporation (the “Company”), maintains the Mentari Therapeutics, Inc. 2025 Equity Incentive Plan (the “Plan”); and

WHEREAS, pursuant to Section 10(d) of the Plan, the Board may amend the Plan at any time.

NOW, THEREFORE, pursuant to its authority under Section 10(d) of the Plan, the Board hereby amends the Plan as follows, effective as of September 18, 2025 (the “Amendment Effective Date”):

 

The first sentence of Section 4(a) of the Plan is hereby amended and restated in its entirety to read as follows:

“Subject to adjustment under Section 8 hereof, Awards may be made under the Plan covering up to 12,079,248 shares of common stock of the Company (the “Common Stock”), all of which may be granted as Incentive Stock Options (as defined below).”

 

…